Last quarter (Q3 2024), Xortx Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Xortx Therapeutics's net income was $-587.01K. See Xortx Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ -162.58K	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ -162.58K	$ ―
Operating Expense	$ 4.66M	$ 6.05M	$ 10.17M	$ 3.65M	$ 1.30M	$ 565.97K
Operating Income	$ -4.66M	$ -6.05M	$ -10.17M	$ -3.65M	$ -1.30M	$ -565.97K
Net Non Operating Interest Income Expense	$ 146.39K	$ 253.54K	$ 103.59K	$ 5.60K	$ 13.51K	$ 37.21K
Other Income Expense	$ -3.80M	$ -3.64M	$ -2.35M	$ 2.00M	$ 29.41K	$ -26.40K
Pretax Income	$ -736.66K	$ -2.16M	$ -7.72M	$ -1.65M	$ -1.28M	$ -629.58K
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -736.66K	$ -2.16M	$ -7.72M	$ -1.65M	$ -1.28M	$ -629.58K
Basic EPS	$ -1.03	$ -1.09	$ -5.22	$ -0.17	$ -0.23	$ -0.12
Diluted EPS	$ -1.03	$ -1.09	$ -5.22	$ -0.17	$ -0.23	$ -0.12
Basic Average Shares	$ 15.89M	$ 1.98M	$ 1.48M	$ 9.85M	$ 6.66M	$ 5.36M
Diluted Average Shares	$ 15.89M	$ 1.98M	$ 1.48M	$ 9.85M	$ 6.66M	$ 5.36M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 3.79M	$ ―	$ 10.17M	$ -3.65M	$ -1.30M	$ -565.97K
Net Income From Continuing And Discontinued Operation	$ -736.66K	$ -2.16M	$ -7.72M	$ -1.65M	$ -1.28M	$ -629.58K
Normalized Income	$ -1.42M	$ -1.59M	$ -5.67M	$ -1.21M	$ -970.63K	$ -462.74K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -736.66K	$ -2.16M	$ -7.72M	$ -1.65M	$ -1.27M	$ -592.36K
EBITDA	$ -621.17K	$ -2.02M	$ -7.66M	$ -1.63M	$ -1.25M	$ -572.46K

Currency in USD

Xortx Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing